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ABSTRACT: Formalin-fixed paraffin-embedded (FFPE) tissue represents the
primary source of clinical tissue and is routinely used in MALDI-MSI studies.
However, it is not particularly suitable for lipidomics imaging given that many
species are depleted during tissue processing. Irrespective, a number of
solvent-resistant lipids remain, but their extraction may be hindered by the
cross-link between proteins. Therefore, an antigen retrieval step could enable
the extraction of a greater number of lipids and may provide information that
is complementary to that which can be obtained from other biomolecules,
such as proteins. In this short communication, we aim to address the effect of
performing antigen retrieval prior to MALDI-MSI of lipids in FFPE tissue. As
a result, an increased number of lipid signals could be detected and may have
derived from lipid species that are known to be implicated in the lipid−protein
cross-linking that is formed as a result of formalin fixation. Human renal
cancer tissue was used as a proof of concept to determine whether using these
detected lipid signals were also able to highlight the histopathological regions that were present. These preliminary findings may
highlight the potential to enhance the clinical relevance of the lipidomic information obtained from FFPE tissue.
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1. INTRODUCTION
Formalin fixation and paraffin embedding (FFPE) of tissue
represents the gold standard for specimen preservation in
pathology units, enabling the long-term storage of samples and
the generation of large tissue banks.1,2 This form of
preservation initiates the process of amine−thiol cross-linking,
and the resulting methylene bridges inactivate enzymatic
activity, stabilizing the biomolecules within the tissue.3 As a
result, FFPE tissue specimens are employed for routine
diagnostic assessment and also represent a valuable source of
molecular information that can be exploited for biomarker
discovery.1,2,4
Although matrix-assisted laser desorption/ionization mass
spectrometry imaging (MALDI-MSI) is now routinely used to
explore the spatial distribution of proteins in FFPE tissue, the
detection of lipid species is somewhat more challenging.5,6
This is primarily related to the phenomenon of many lipid
species being depleted from the tissue by the use of paraffin
wax and organic solvents during the processing of the tissue.7
Nevertheless, recent studies employing MALDI-MSI8 and
Fourier transform infrared spectroscopy9 have provided
evidence to suggest that some of these solvent-resistant lipid
species are maintained in FFPE tissues and may provide
diagnostically relevant information.
Among these solvent-resistant lipids, a proportion of them
may be confined within the covalent network of proteins
formed during fixation and may not be efficiently extracted.
Therefore, an antigen retrieval (AR)10 step prior to MALDI-
MSI analysis, as is traditionally performed in protocols for the
MSI of tryptic peptides,11−14 may enable access to these lipids
and increase the coverage of species detected.
In this work, we explore the effect of AR on the MALDI-
MSI detection of lipid species in FFPE tissue, observing an
increased number of lipid species in human renal tissue that
also better reflected the heterogeneous morphology of the
specimens. These preliminary results indicate that AR may
help to enhance the degree of lipidomic information that can
be obtained from FFPE tissue using MALDI-MSI.
2. EXPERIMENTAL SECTION
2.1. Specimen Selection. The FFPE blocks selected for
this study included normal kidney and clear cell renal cell
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carcinoma (ccRCC), both from nephrectomy specimens
performed for neoplasia at the University of Milano-Bicocca,
San Gerardo Hospital, Monza, Italy.15 The appropriate Ethical
Committee approved the collection of these specimens, and
informed consent was obtained from all participants.
2.2. Fixation and Cutting. Fixation time was set at 24 h
following the surgical procedure, as previously described. Four-
micron-thick sections were cut and mounted onto conductive
glasses coated with indium tin oxide (Bruker Daltonik GmbH,
Bremen, Germany).1 The slides were stocked at room
temperature until the day of the analysis.
2.3. Sample Preparation. For positive ion imaging,
consecutive tissue sections from five FFPE blocks were
prepared using a protocol without an antigen retrieval step
(A) and with an antigen retrieval step (B). The latter protocol
(B) was then used to analyze another tissue that was
characterized by more complex histopathological features.
Finally, an additional two cases of ccRCC were analyzed using
protocols A and B for preliminary negative ion imaging
analysis.
In both protocols (A and B), the slides were first
deparaffinized and rehydrated by performing consecutive
washes with toluene (2 × 5 min), isopropyl alcohol (1 × 5
min), 100% ethanol (1 × 5 min), 90% ethanol (1 × 5 min),
and 70% ethanol (1 × 3 min).
In protocol A, the tissue was brought to hydration by
washing in HPLC grade H2O for 2 min prior to matrix
application. In protocol B, the slides were washed twice in
HPLC grade H2O for 3 min each. The antigen retrieval was
performed in a bath of 10 mM citric acid buffer at 97 °C for 45
min before being brought to hydration by washing in HPLC
grade H2O for 2 min prior to matrix application.
2.4. Matrix Application. For positive ion imaging,
equimolar quantities of aniline and 10 mg/mL α-cyano-4-
hydroxycinnamic acid (ANI-CHCA)16 were dissolved in a 70%
methanol solution with 0.1% trifluoroacetic acid. This matrix
solution was deposited using the HTX TM-Sprayer (HTX
Technologies, LLC), with the following parameters: temper-
ature = 75 °C; number of passes = 2; flow rate = 0.06 mL/min;
velocity = 1200 mm/min; track spacing = 1.2 mm; pressure =
5 psi.
For negative ion imaging, 10 mg/mL 9-aminoacrdine was
dissolved in a 70% methanol solution and deposited using the
HTX TM-Sprayer (HTX Technologies, LLC), with the
following parameters: temperature = 85 °C; number of passes
= 6; flow rate = 0.2 mL/min; velocity = 1100 mm/min; track
spacing = 2 mm; pressure = 10 psi.
2.5. MALDI-MSI. All analyses were performed using a
rapifleX MALDI Tissuetyper mass spectrometer (Bruker
Daltonics, Bremen, Germany) equipped with a Smartbeam
Figure 1. (a) Example MALDI-MS images of consecutive sections analyzed without antigen retrieval (protocol A; left) and with antigen retrieval
(protocol B; right), highlighting the localization of two signals. In samples prepared with protocol B, the signals at m/z 518.35 (LPC18:3) and at
m/z 520.34 (LPC 18:2) had a higher intensity in the tumor region, as indicated by a purple line in the H&E image (center), whereas the signal at
m/z 776.55 (PC(34:4) + Na) and at m/z 812.56 (PS 36:1) had a higher intensity in the nontumor region, as indicated by the green line in the
H&E image. The same signals were not detected in the samples prepared with protocol A. (b) MALDI-MS profiles of the two regions highlighted
in the H&E image. On the left (red rectangle) are average spectra from the tumor (purple) and the nontumor (green) regions analyzed using
protocol A. On the right (blue rectangle) are average spectra from the tumor (purple) and the nontumor (green) regions analyzed using protocol
B. Those peaks assigned to α-CHCA matrix clusters are indicated by the \\ symbols.
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3D laser. External calibration was performed using red
phosphorus clusters in the m/z range of 0 to 2000.17 Mass
measurements in positive ion reflectron mode were acquired in
the m/z range of 420 to 820, whereas mass measurements in
negative ion reflectron mode were acquired in the m/z range of
500 to 900. In both instances, 400 shots were accumulated for
each spectrum and the matrix suppression deflection was set to
m/z 400. The samples were rastered at a lateral resolution 50 ×
50 (x,y) μm with a laser scan range of 44 μm per pixel.
2.6. On-Tissue MALDI-MS/MS. A single precursor ion was
selected by using the smallest precursor ion selector window
possible and dissociated using LID-LIFT technology,18 with
the laser energy being set within a range of 40−70%. This
process was performed until an MS/MS spectrum was
obtained from the accumulation of ∼100,000 laser shots.
2.7. Histological Staining. Following MALDI-MS anal-
ysis, tissue sections were washed with ethanol (70 and 100%)
and the slides were stained using hematoxylin and eosin
(H&E).19 The slides were converted to digital format by
scanning using a ScanScope CS digital scanner (Aperio, Park
Center Dr., Vista, CA, USA).1
2.8. Data Processing. Data files containing the individual
spectra of each entire measurement region were imported into
SCiLS Lab MVS 2019b software (http://scils.de/; Bremen,
Germany) for spectra preprocessing and to annotate regions of
interest (ROIs). Average spectra of those samples analyzed
without AR (protocol A) or with AR (protocol B) were
generated.1,19 These average spectra were then imported into
mMass (version 5.5.0, http://www.mmass.org), where peak
picking (S/N ≥ 5) was performed.20,21Finally, a reference list
of α-CHCA cluster signals22 was imported into mMass, and if
a matrix peak was matched with a mass tolerance of ≤50 ppm,
it was removed from the final peak list.
For lipid identification, product ions in the acquired
MALDI-MS/MS spectra were annotated within mMass after
being cross-referenced with known product ions generated by
the fragmentation of different phospholipid species.23−25 Then,
identifications were assigned by matching the mass of the
precursor ion with lipids listed in the METLIN,26 HMDB,27
and Lipid Maps28 databases.
3. RESULTS AND DISCUSSION
When assessing the effect of antigen retrieval on the detection
of positive ion lipid species in FFPE tissue, the total number of
peaks detected in the tissue treated without AR (protocol A)
was 74, whereas with AR (protocol B), a total number of 129
peaks were detected. Moreover, we observed that the signals
detected with protocol B enabled the tissue to be separated
into the tumoral and nontumoral regions indicated by the
H&E staining (Figure 1a), with these signals not being
detected when using protocol A. This was also evident in the
average spectra generated for the tumor and nontumor regions
(Figure 1b), with distinct differences between them only being
observed when antigen retrieval was performed. On the
contrary, we observed that the signals obtained with protocol A
did not reflect the morphology of the samples analyzed. This
effect is further highlighted in Supplemental Figure S1. Given
the low abundance of the lipids extracted by the matrix, the
differences in signal intensities could be more related to tissue
density and variations on extraction efficiency rather than any
histopathological differences within the tissue.
Figure 2. (a) H&E-stained images of the two additional tissue sections analyzed. The regions of interest (ROIs) are annotated with different colors.
(b) MALDI-MS images of four m/z signals localized in specific regions of three different samples and indicated by triangles. Color scale bars are
provided to represent relative signal intensity. The m/z 518.35 (LPC 18:3) is more intense in the tumor regions, whereas m/z 812.56 (PS 36:1)
and 810.61 (PC(36:4)+Na) are of higher intensity in both the cortex and necrotic regions. Finally, m/z 616.17 (heme) is present solely in the
hemorrhagic regions. (c) Average spectra of the ROIs indicated in the H&E-stained image. Arrows indicate the peaks highlighted in MALDI-MS
images.
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In order to further evaluate the possibility to detect
regiospecific profiles when performing an AR step, two
additional specimens, which were characterized by more
complex histopathology, were analyzed. The tumoral, cortical,
necrotic, and hemorrhagic regions present within these tissue
sections (Figure 2a) could also be spatially resolved using
individual m/z signals at 518.35, 812.56, 810.61, 788.64, and
616.17 (the latter corresponding with a fragment of the heme
group29,30) (Figure 2b). These regiospecific signatures were
also evident in the average profiles generated from these ROIs
(Figure 2c) and support the proposal that it can be possible to
still detect clinically relevant lipid species in FFPE samples,
despite the loss of a large proportion during tissue processing.
In order to gain an initial understanding of the phospholipid
classes that AR renders more accessible, on-tissue MALDI-
MS/MS was performed on the primary signals whose
distribution was in agreement with the histology of the tissue.
An overview of the product ions generated and the resulting
lipid identifications are provided in Supplemental Table S1a.
Briefly, a number of different lipid species were identified,
including phosphatidylcholine (PC), as well as their lyso
variants (LPC), and sphingomyelin (SM), with these lipid
species already reported to be readily detected in fixed
tissue.31,32 Although it seems that PC and SM are not directly
involved in the amine−thiol cross-linking, those that remain
after the process of paraffin embedding are part of the
membrane protein−lipid complex. As such, we could speculate
that their extraction is rendered more efficient without the
steric hindrance caused by the presence of large protein
complexes.33 Moreover, a phosphatidylserine (PS) lipid was
also identified, and this can be particularly relevant given that
the headgroups of PS lipids react directly with formalin to
promote the formation of cross-links between themselves and
other amine-containing molecules.7 Thus, this finding may
serve as further evidence of the effect that AR has on the
detection of positive ion lipid species in FFPE tissue.
Preliminary analysis in negative ion mode was also
performed in order to evaluate the effect of AR on the
detection of further phospholipid classes whose ionization in
positive ion mode can be hindered by the presence of PC.34 In
this instance, lipid signals whose spatial distribution was
coherent with tissue morphology were detected using both
protocols (A and B) (Supplemental Figure S2). Among these,
some phosphatidic acid, phosphatidylglycerol, and phosphati-
dylinositol species were detected both without and with AR
(Supplemental Table S1b) and is in accordance with previous
observations where negative ion MALDI-MS imaging of FFPE
tissue was performed.8 Whereas there were further m/z signals
detected exclusively in the tissue prepared with AR, their
identification was hindered by difficulties encountered in
precursor ion selection and the resulting complexity of the on-
tissue MS/MS spectra (data not shown). Accordingly, a more
systematic approach, employing high mass accuracy MS and
ion mobility,35 should be considered in order to obtain a more
comprehensive overview of the solvent-resistant lipid classes
that become accessible as a result of performing antigen
retrieval.
4. CONCLUSIONS
Whereas many nonpolar lipid species are depleted from FFPE
specimens during the processing of the tissue, some solvent-
resistant lipids may remain present and locked in the cross-
linked network that arises as a result of formalin fixation.36 The
introduction of an antigen retrieval step seems to increase the
number of these solvent-resistant lipids (PC, LPS, SM, and PS)
that can be detected in FFPE tissue samples when performing
MALDI-MSI. We have observed that the protocol is able to
maintain the specific localization of these lipids signals in
different areas of ccRCC tissue, used as testing a specimen,
according to their histopathological features, and by exploiting
this lipidomic information, it may then be possible to obtain
clinically relevant information. In conclusion, these highly
promising findings indicate that it may be possible to detect
alterations in the spatial lipidome of FFPE tissue, opening up
new possibilities for spatial omics investigations of disease.
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